Invent a disease, then sell drugs to “cure” it.

From The Verge

Soon, children may be diagnosed with another attention disorder.
Psychologists are working to determine if sluggish cognitive tempo (SCT) — marked by daydreaming, mind-wandering, and lethargy — has a clear set of symptoms and can join the ranks as a legitimate disorder. If it does, it’d open up an opportunity for more pharmaceutical treatments in an area that some experts argue is already over-diagnosed and over-medicated due to attention deficit hyperactivity disorder (ADHD). As detailed in a New York Times article, experts question whether proponents of minting another attention disorder are merely interested in expanding what’s already a multi-billion dollar business spurred by marketing efforts.

New York Times article:


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s